British Columbia securities regulators are investigating a now-defunct ketamine therapy company that has been previously accused of defrauding investors. 

A lawyer for the B.C. Securities Commission (BCSC) said at a recent hearing that the commission is looking into Braxia Scientific Corp., an Ontario-based company that offered ketamine as a depression treatment and researched the medical applications of psychedelic drugs.